Das Sommerekzem – neue Ansätze in Diagnostik und Therapie

Eine erfolgreiche Behandlung des Sommerekzems basiert auf dem Verständnis der Pathomechanismen und den daraufhin entwickelten und optimierten diagnostischen Tests. Hier gibt es einige neue Ansätze, ebenso wie bei den Allergen-unabhängigen Therapiemöglichkeiten.

Publication History

Article published online:
21 September 2022

• Literatur

• 1 Miller JE, Mann S, Fettelschoss-Gabriel A, Wagner B. Comparison of three clinical scoring systems for Culicoides hypersensitivity in a herd of Icelandic horses. Vet Derm 2019; 30: 536-e163
• 2 Wagner B. Pathogenesis and epidemiology of Culicoides hypersensitivity. In: Noli C, Foster A, Rosenkrantz W eds. Veterinary Allergy. Ames, IA: Wiley Blackwell; 2014: 275-286
• 3 Riek R. Studies on allergic dermatitis (Queensland itch) of the horse I. Description, distribution, symptoms and pathology. Austral Vet J 1953; 177-184
• 4 McCaig J. A survey to establish the incidence of sweet itch in ponies in the United Kingdom. Vet Rec 1973; 93: 444-446
• 5 Littlewood JD. Incidence of recurrent seasonal pruritus (‘sweet itch’) in British and German shire horses. Vet Rec 1998; 142: 66-67
• 6 Cox A, Wood K, Coleman G, Stewart AJ, Bertin FR, Owen H, Suen WW, Medina-Torres CE. Essential oil spray reduces clinical signs of insect bite hypersensitivity in horses. Austral Vet J 2020; 98 (08) 411-416
• 7 Jonsdottir S, Torsteinsdottir S, Svansson V, Gudbrandsson J, Stefansdottir SB, Bjornsson JM, Runarsdottir A, Marti E. Comparison of recombinant Culicoides allergens produced in different expression systems for IgE serology of insect bite hypersensitivity in horses of different origins. Vet Immunol Immunopath 2021; 238
• 8 Schaffartzik A, Hamza E, Janda J, Crameri R, Marti E, Rhyner C. Equine insect bite hypersensitivity: What do we know?. Vet Immunol Immunopath 2012; 147: 113-126
• 9 Sommer-Locher B, Endriss V, Fromm E. Various circumstances regarding initial allergen exposure and their influence on development of insect bite hypersensitivity in horses. J Equine Vet Sci 2012; 32: 158-163
• 10 Wilson AD, Harwood LJ, Bjornsdottir S, Marti E, Day MJ. Detection of IgG and IgE serum antibodies to Culicoides salivary gland antigens in horses with insect dermal hypersensitivity (sweet itch). Equine Vet J 2001; 33: 707-713
• 11 Greiner EC, Fadok VA, Rabin EB. Equine Culicoides hypersensitivity in Florida: biting midges collected in light traps near horses. Medical Vet Entomol 1988; 2: 129-135
• 12 Sloet van Oldruitenborgh-Osterbaan MM. Immune mediated and allergic diseases. In: Sloet van Oldruitenborgh-Oosterbaan MM, Knottenbelt, DC, Hrsg. Practitionerʼs guide to equine dermatology. Leeuwarden, The Netherlands: Libre; 2001: 52-53
• 13 Baker KP, Quinn PJ. A report on clinical aspects and histopathology of sweet itch. Equine Vet J 1978; 10: 243-248
• 14 van der Rijt R, van den Boom R, Jongema Y, van Oldruitenborgh-Oosterbaan MM. Culicoides species attracted to horses with and without insect hypersensitivity. Vet J 2008; 178: 91-97
• 15 Steinman A, Peer G, Klement E. Epidemiological study of Culicoides hypersensitivity in horses in Israel. Vet Rec 2003; 152: 748-751
• 16 Quinn PJ, Baker KP, Morrow AN. Sweet itch: Responses of clinically normal and affected horses to intradermal challenge with extracts of biting insects. Equine Vet J 1983; 15: 266-272
• 17 Fadok VA, Greiner EC. Equine insect hypersensitivity: skin test and biopsy results correlated with clinical data. Equine Vet J 1990; 22: 236-240
• 18 Greiner EC, Fadok VA, Rabin EB. Equine Culicoides hypersensitivity in Florida: biting midges aspirated from horses. Med Vet Entomol 1990; 4: 375-381
• 19 Baselgia S, Doherr MG, Mellor P, Torsteinsdottir S, Jermann T, Zurbriggen A, Jungi T, Marti E. Evaluation of an in vitro sulphidoleukotriene release test for diagnosis of insect bite hypersensitivity in horses. Equine Vet J 2006; 38: 40-46
• 20 Schaffartzik A, Marti E, Crameri R, Rhyner C. Cloning, production and characterization of antigen 5 like proteins from Simulium vittatum and Culicoides nubeculosus, the first cross-reactive allergen associated with equine insect bite hypersensitivity. Vet Immunol Immunopath 2010; 137: 76-83
• 21 Jonsdottir S, Cvitas I, Svansson V, Fettelschoss-Gabriel A, Torsteinsdottir S, Marti E. New strategies for prevention and treatment of insect bite hypersensitivity in horses. Current Dermatol Rep 2019; 8: 303-312
• 22 Riek R. Studies on allergic dermatitis (Queensland Itch) of the horse: the origin and significance of histamine in the blood and its distribution in the tissues. Austral J Agricult Res 1955; 6: 161-170
• 23 Anderson GS, Belton P, Kleider N. Culicoides obsoletus (Diptera: Ceratopogonidae) as a causal agent of Culicoides hypersensitivity (sweet itch) in British Columbia. J Med Entomol 1991; 28: 685-693
• 24 Kurotaki T, Narayama K, Oyamada T, Yoshikawa H, Yoshikawa T. Immunopathological study on equine insect hypersensitivity (‘kasen’) in Japan. J Comp Pathol 1994; 110: 145-152
• 25 van der Haegen A, Griot-Wenk M, Welle M, Busato A, von Tscharner C, Zurbriggen A, Marti E. Immunoglobulin-E-bearing cells in skin biopsies of horses with insect bite hypersensitivity. Equine Vet J 2001; 33: 699-706
• 26 Wagner B, Miller WH, Morgan EE, Hillegas JM, Erb HN, Leibold W, Antczak DF. IgE and IgG antibodies in skin allergy of the horse. Vet Res 2006; 37: 813-825
• 27 Cunningham FM, Dunkel B. Equine recurrent airway obstruction and insect bite hypersensitivity: Understanding the diseases and uncovering possible new therapeutic approaches. Vet J 2008; 177: 334-344
• 28 Fettelschoss-Gabriel A, Birkmann K, Pantelyushin S, Kündig TM. Molecular mechanisms and treatment modalities in equine Culicoides hypersensitivity. Vet J 2021; 276: 105741 Epub 2021 Aug 17
• 29 Benarafa C, Collins ME, Hamblin AS, Cunningham FM. Role of the chemokine eotaxin in the pathogenesis of equine sweet itch. Vet Rec 2002; 151: 691-693
• 30 Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979; 123: 2925-2927
• 31 Gleich GJ, Adolphson CR. The eosinophilic leukocyte: Structure and function. In: Advances in Immunology. Academic Press; 1986: 177-253
• 32 Tai PC, Hayes DJ, Clark JB, Spry CJF. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J 1982; 204: 75-80
• 33 Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D, Janss T, Starkl P, Ramery E, Henket M. et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Investig 2016; 126: 3279-3295
• 34 Van Hulst G, Batugedara HM, Jorssen J, Louis R, Bureau F, Desmet CJ. Eosinophil diversity in asthma. Biochem Pharmacol 2020; 179: 113963
• 35 Fettelschoss-Gabriel A, Fettelschoss V, Thoms F, Giese C, Daniel M, Olomski F, Kamarachev J, Birkmann K, Bühler M, Kummer M. et al. Treating insect- bite hypersensitivity in horses with active vaccination against IL-5. J Allergy Clin Immunol 2018; 142: 1194-1205.e1193
• 36 Gonzales AJ, Fleck TJ, Humphrey WR, Galvan BA, Aleo MM, Mahabir SP, Tena JK, Greenwood KG, McCall RB. IL-31-induced pruritus in dogs: A novel experimental model to evaluate anti-pruritic effects of canine therapeutics. Vet Dermatol 2016; 27: 34-e10
• 37 Lewis KE, Holdren MS, Maurer MF, Underwood S, Meengs B, Julien SH, Byrnes-Blake KA, Freeman JA, Bukowski TR, Wolf AC. et al. Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody. J Eur Acad Dermatol Venereol 2017; 31: 142-150
• 38 Lu J, Wu K, Zeng Q, Xiang Y, Gao L, Huang J. Serum interleukin-31 level and pruritus in atopic dermatitis: A meta-analysis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2018; 43: 124-130
• 39 Besner Morin C, Misery L. Emerging treatments and novel pathways in pruritus. L Cutaneous Med Surg 2019; 23: 528-536
• 40 Olomski F, Fettelschoss V, Jonsdottir S, Birkmann K, Thoms F, Marti E, Bachmann MF, Kundig TM, Fettelschoss-Gabriel A. Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch. Allergy 2020; 75: 862-871
• 41 Cvitas I, Oberhaensli S, Leeb T, Dettwiler M, Müller E, Bruggman R, Marti E. Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity. PLoS One 2020; 15: e0232189
• 42 Cvitas I, Galichet A, Ling SC, Müller EJ, Marti E. Toll-like receptor-ligand induced thymic stromal lymphopoietin expression in primary equine keratinocytes. Vet Dermatol 2020; 31: 154-162
• 43 Vychodilova L, Matiasovic J, Bobrova O, Futas J, Klumplerova M, Stejskalova K, Cvanova M, Janova E, Osickova J, Vyskocil M. et al. Immunogenomic analysis of insect bite hypersensitivity in a model horse population. Vet Immunol Immunopath 2013; 152: 260-268
• 44 Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, Hansen JB, Dissing S, Malling HJ, Skov PS. et al. CXCR3 Expression and activation of eosinophils: Role of IFN-γ-inducible protein-10 and monokine induced by IFN-γ. J Immunol 2000; 165: 1548-1556
• 45 Dajotoy T, Andersson P, Bjartell A, Löfdahl CG, Tapper H, Egesten A. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. J Leukocyte Biol 2004; 76: 685-691
• 46 Frey R, Bergvall K, Egenvall A. Allergen-specific IgE in Icelandic horses with insect bite hypersensitivity and healthy controls, assessed by FcepsilonR1alpha-based serology. Vet Immunol Immunopath 2008; 126: 102-109
• 47 Peeters LM, Janssens S, Goddeeris BM, De Keyser K, Wilson AD, Kaufmann C, Schaffartzik A, Marti E, Buys N. Evaluation of an IgE ELISA with Culicoides spp. extracts and recombinant salivary antigens for diagnosis of insect bite hypersensitivity in Warmblood horses. Vet J 2013; 198: 141-147
• 48 Morgan EE, Miller Jr WH, Wagner B. A comparison of intradermal testing and detection of allergen-specific immunoglobulin E in serum by enzyme-linked immunosorbent assay in horses affected with skin hypersensitivity. Vet Immunol Immunopath 2007; 120: 160-167
• 49 Wagner B, Radbruch A, Rohwer J, Leibold W. Monoclonal anti-equine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE. Vet Immunol Immunopath 2003; 92: 45-60
• 50 Anderson GS, Belton P, Kleider N. Hypersensitivity of horses in British Columbia to extracts of native and exotic species of Culicoides (Diptera: Ceratopogonidae). J Med Entomol 1993; 30: 657-663
• 51 Ferroglio E, Pregel P, Accossato A, Taricco I, Bollo E, Rossi L, Trisciuoglio A. Equine Culicoides hypersensitivity: Evaluation of a skin test and of humoral response. J Vet Med/Series A Physiol Pathol, Clinical Med 2006; 53: 30-33
• 52 Hellberg W, Mellor PS, Torsteinsdóttir S, Marti E. Insect bite hypersensitivity in the horse: Comparison of IgE-binding proteins in salivary gland extracts from Simulium vittatum and Culicoides nubeculosus . Vet Immunol Immunopathol 2009; 132: 62-67
• 53 Schurink A, van der Meide NM, Savelkoul HF, Ducro BJ, Tijhaar E. Factors associated with Culicoides obsoletus complex spp.-specific IgE reactivity in Icelandic horses and Shetland ponies. Vet J 2014; 201: 395-400
• 54 van der Meide NM, Savelkoul HF, Meulenbroeks C, Ducro BJ, Tijhaar E. Evaluation of a diagnostic ELISA for insect bite hypersensitivity in horses using recombinant Obsoletus complex allergens. Vet J 2014; 200: 31-37
• 55 Halldorsdottir S, Larsen HJ, Mehl R. Intradermal challenge of Icelandic horses with extracts of four species of the genus Culicoides . Res Vet Sci 1989; 47: 283-287
• 56 Kolm-Stark G, Wagner R. Intradermal skin testing in Icelandic horses in Austria. Equine Vet J 2002; 34: 405-410
• 57 Lebis C, Bourdeau P, Marzin-Keller F. Intradermal skin tests in equine dermatology: A study of 83 horses. Equine Vet J 2002; 34: 666-671
• 58 Wagner B, Miller Jr WH, Erb HN, Lunn DP, Antczak DF. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses. Vet Immunol Immunopath, 2009; 132: 53-56
• 59 van Damme CMM, van den Broek J, Sloet van Oldruitenborgh-Oosterbaan MM. Discrepancies in the bilateral intradermal test and serum tests in atopic horses. Vet Dermatol 2020; 31 (05) 390-e104
• 60 Berrens L. What is a ‘major’ allergen?. Clinical and Experimental Allergy 1994; 24: 606-609 discussion 610-601
• 61 Novotny EN, White S, Wilson AD, Stefánsdóttir SB, Tijhaar E, Jonsdottir S, Frey R, Reiche D, Rose H, Rhyner C. et al. Component-resolved microarray analysis of IgE sensitization profiles to Culicoides recombinant allergens in horses with insect bite hypersensitivity. Allergy 2021; 1147-1157
• 62 Huhmann R, Mueller RS. A cream containing omega-3-fatty acids, humectants and emollients as an aid in the treatment of equine Culicoides hypersensitivity. Vet Dermatol 2019; 30: 155-e146
• 63 Morrow A, Quinn PJ, Baker KP. Dermal reactivity to histamine, serotonin and bradykinin in relation to allergic skin reactions of the horse. J Vet Pharmacol Therapeut 1986; 9: 40-48
• 64 Foster AP, McKelvie J, Cunningham FM. Inhibition of antigen-induced cutaneous responses of ponies with insect hypersensitivity by the histamine-1 receptor antagonist chlorpheniramine. Vet Rec 1998; 143: 189-193
• 65 Petersen A, Schott HC. Effects of dexamethasone and hydroxyzine treatment on intradermal testing and allergen-specific IgE serum testing results in horses. Vet Dermatol 2009; 20: 615-622
• 66 Leclere M. Corticosteroids and immune suppressive therapies in horses. Vet Clin North Am: Equine Practice 2017; 33: 17-27
• 67 Olsén L, Bondesson U, Broström H, Olsson U, Mazogi B, Sundqvist M, Tjälve H, Ingvast-Larsson C. Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity. Vet J 2011; 187: 347-351
• 68 Cassard L, Jönsson F, Arnaud S, Daëron M. Fcγ receptors inhibit mouse and human basophil activation. J Immunol 2012; 189: 2995-3006
• 69 Malbec O, Cassard L, Albanesi M, Jönsson F, Mancardi D, Chicanne G, Payrastre B, Dubreuil P, Vivier E, Daëron M. Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. Sci Signal 2016; 9: ra126
• 70 Mueller RS, Jensen-Jarolim E, Roth-Walter F, Marti E, Janda J, Seida AA, DeBoer D. Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs. Allergy 2018; 73: 1989-1999
• 71 Barbet JL, Bevier D, Greiner EC. Specific immunotherapy in the treatment of Culicoides hypersensitive horses: A double-blind study. Equine Vet J 1990; 22: 232-235
• 72 Anderson GS, Belton P, Jahren E, Lange H, Kleider N. Immunotherapy trial for horses in British Columbia with Culicoides (Diptera: Ceratopogonidae) hypersensitivity. J Med Entomol 1996; 33: 458-466
• 73 Stepnik CT, Outerbridge CA, White SD, Kass PH. Equine atopic skin disease and response to allergen-specific immunotherapy: a retrospective study at the University of California-Davis (1991–2008). Vet Dermatol 2012; 23: 29-35
• 74 Jonsdottir S, Hamza E, Janda J. et al. Developing a preventive immunization approach against insect bite hypersensitivity using recombinant allergens: a pilot study. Vet Immunol Immunopathol 2015; 166: 8-21
• 75 Jonsdottir S, Svansson V, Stefansdottir SB. et al. A preventive immunization approach against insect bite hypersensitivity: intralymphatic injection with recombinant allergens in Alum or Alum and monophospphoryl lipid A. Vet Immunol Immunopathol 2016; 172: 14-20
• 76 Jonsdottir S, Svansson V, Stefansdottir SB, Mantyla E, Marti E, Torsteinsdottir S. Oral administration of transgenic barley expressing a Culicoides allergen induces specific antibody response. Equine Vet J 2017; 49: 512-518
• 77 Castro M, Zangrilli J, Wechsler ME. et al. Reslizumab for inade- quately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Resp Med 2015; 3 (05) 355-366
• 78 FitzGerald JM, Bleecker ER, Nair P. et al. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2016; 388(10056): 2128-2141
• 79 Ortega HG, Liu MC, Pavord ID, Bruselle GG, FitzGerald JM, Chetta A. et al. Mepolizumab treatment in patients with severe eosinophilic asthma. New England J Med 2014; 371 (13) 1198-1207
• 80 Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD. et al. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis. Vet Dermatol 2016; 27 (06) 478-e129
• 81 Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD. et al. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Vet Dermatol 2016; 27 (06) 505-e136
• 82 Fettelschoss-Gabriel A, Fettelschoss V, Olomski F, Birkmann K, Thoms F, Buhler M, Kummer M, Zeltins A, Kundig TM, Bachmann MF. Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses. Allergy 2019; 74: 572-582
• 83 Fettelschoss V, Olomski F, Birkmann K, Kündig TM, Bergvall K, Fettelschoss-Gabriel A. Interleukin 31 and targeted vaccination in a case series of six horses with chronic pruritus. Equine Vet Educ 2020; 33 (12) e490-e500
• 84 Jonsdottir S, Fettelschoss V, Olomski F, Talker SC, Mirkovitch J, Rhiner T, Birkmann K, Thoms F, Wagner B, Bachmann MF. et al. Safety profile of a virus-like particle-based vaccine targeting self-protein interleukin-5 in horses. Vaccines (Basel) 2020; 8